Kailera Therapeutics (KLRA) EBT Margin (2025 - 2026)
Kailera Therapeutics (KLRA) recorded EBT Margin of -1381.11% in Q1 2026, down 259.73 percentage points from -1121.37% a year earlier.
Powered by 
Analysis
Kailera Therapeutics (KLRA) EBT Margin (2025 - 2026) Analysis & Trends
On a TTM basis, Kailera Therapeutics' EBT Margin came in at -6883.01% as of Mar 31, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Kailera Therapeutics | 1.72 Bn | -1.16 Bn | - | - |
API Access
Kailera Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=KLRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "KLRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=KLRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();